ADVANCED EPITHELIOID SARCOMA

Clinical trials for ADVANCED EPITHELIOID SARCOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED EPITHELIOID SARCOMA trials appear

Sign up with your email to follow new studies for ADVANCED EPITHELIOID SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Early-Stage trial for Ultra-Rare cancer halted

Disease control Terminated

This early-stage trial tested whether adding a new drug, tazemetostat, to a standard chemotherapy (doxorubicin) was safe and could help control an ultra-rare and aggressive cancer called epithelioid sarcoma. The study was small and ended early, so it only gathered initial safety …

Matched conditions: ADVANCED EPITHELIOID SARCOMA

Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

ADVANCED EPITHELIOID SARCOMA

Get alerted when new ADVANCED EPITHELIOID SARCOMA trials appear

Early-Stage trial for Ultra-Rare cancer halted